» Articles » PMID: 16163009

Hyperosmolar Saline is a Proinflammatory Stress on the Mouse Ocular Surface

Overview
Specialty Ophthalmology
Date 2005 Sep 16
PMID 16163009
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate whether hyperosmolar stress stimulates production of inflammatory mediators and activates the mitogen-activated protein kinase (MAPK) signaling pathways, c-jun n-terminal kinases (JNKs), extracellular-regulated kinases (ERKs), and p38 on the mouse ocular surface.

Methods: 129SvEv/CD-1 mixed mice were treated with a balanced salt solution (BSS) (305 mOsM) or a hyperosmotic saline solution (HOSS) (500 mOsM). Untreated age-matched mice were used as controls. The concentrations of interleukin 1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha) were measured by enzyme-linked immunosorbent assay. Gelatinase activity was determined by in situ zymography. Corneal and conjunctival epithelia were lysed for Western blot with MAPK antibodies or used for semiquantitative reverse transcription and polymerase chain reaction and gene array.

Results: Compared with age-matched controls and mice treated with BSS, the concentration of IL-1beta in tear fluid washings and the concentrations of IL-1beta and TNF-alpha and gelatinolytic activity in the corneal and conjunctival epithelia were significantly increased in mice treated with HOSS for 2 days. The expressions of IL-1beta, TNF-alpha, and matrix metalloproteinase 9 (MMP-9) messenger RNA by the corneal and conjunctival epithelia were also notably stimulated in mice treated with HOSS. The levels of phosphorylated JNK1/2, ERK1/2, and p38 MAPKs in the corneal and conjunctival epithelia were slightly increased in mice treated with BSS, but markedly increased in mice treated with HOSS.

Conclusions: These results show that the hyperosmolarity stimulates expression and production of IL-1beta, TNF-alpha, and MMP-9 and activates JNK, ERK, and p38 MAPK signaling pathways on the mouse ocular surface. These findings suggest that hyperosmolar stress, as it may occur in dry eye, promotes ocular surface inflammation.

Citing Articles

Ophthalmic Formulations for the Treatment of Allergic Conjunctivitis and Their Effect on the Ocular Surface: A Review of Safety and Tolerability Assessments in Clinical Trials.

Suarez-Cortes T, Gonzalo A, Arana E, Guillen V, Andollo N J Clin Med. 2024; 13(22).

PMID: 39598046 PMC: 11595245. DOI: 10.3390/jcm13226903.


A Novel Noninvasive Screening Tool for Dry Eye Disease.

Vaccaro S, Borselli M, Scalia G, Rossi C, Toro M, Rejdak R Diagnostics (Basel). 2024; 14(12).

PMID: 38928625 PMC: 11202972. DOI: 10.3390/diagnostics14121209.


A Novel Ophthalmic Solution Containing Glicopro Complex for the Treatment of Patients with Dry Eye Disease: Results from a Pilot Study.

Giannaccare G, Vaccaro S, Borselli M, Rossi C, Scalzo G, Scalia G J Clin Med. 2024; 13(5).

PMID: 38592312 PMC: 10932378. DOI: 10.3390/jcm13051447.


Impact of Clinician Subjectivity on the Assessment of Dry Eye Disease Prevalence in a UK Public Health Care Patient Population.

Sullivan B, Smith G, Gupta A, Harman F, Ansari E Clin Ophthalmol. 2024; 18:743-753.

PMID: 38476359 PMC: 10929644. DOI: 10.2147/OPTH.S452149.


Feasibility of Tear Meniscus Height Measurements Obtained with a Smartphone-Attachable Portable Device and Agreement of the Results with Standard Slit Lamp Examination.

Borselli M, Toro M, Rossi C, Taloni A, Khemlani R, Nakayama S Diagnostics (Basel). 2024; 14(3).

PMID: 38337832 PMC: 10855891. DOI: 10.3390/diagnostics14030316.